Eli Lilly’s latest TV ad, unveiled during the Grammys on Sunday night, highlights the importance of early diagnosis for ...

Many Americans have turned to Hims & Hers and other telehealth companies for copies of weight-loss drugs after struggling to ...

So far in 2025, the year’s biggest cultural events have served as launchpads for several of the industry's latest cancer ...

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy ... of tirzepatide (branded as Mounjaro and Zepbound), Eli Lilly and Co. (NYSE: LLY) was another key pharma ...

New treatments can slow the disease’s progress, which is why the Alzheimer’s Association is leveraging its celebrity partners ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... stable financial performance, and strong brand recognition. In an interview on January 22, Dave Sekera ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... stable financial performance, and strong brand recognition. In an interview on January 22, Dave Sekera, US Market ...